pre-ipo cfo.

Led by a visionary founder and a scientific committee of industry veterans. You will be joining a highly dynamic and ambitious executive board, reporting directly to the CEO, and acting as the primary bridge between the company's scientific innovations and the global capital markets.
about the job.

• IPO Execution: Spearhead the company's upcoming HKEX Chapter 18A IPO process, leading the coordination with global sponsors, legal counsels, and auditors.

• Capital Strategy & IR: Formulate and execute comprehensive capital market strategies, actively pitch to top-tier institutional investors, and secure future financings.

• Strategic Finance & BD Support: Oversee group-level financial planning, build complex valuation models, and provide critical financial leadership for cross-border Business Development (License-in/out) and M&A activities.

skills and experience required.

• Capital Market Track Record: Proven experience in successfully executing HKEX 18A IPOs, either as an in-house Biotech CFO or as a senior investment banker (VP/ED/MD level) from top-tier global or domestic securities firms.

• Technical Expertise: Exceptional financial modeling and valuation capabilities, with a deep understanding of biotech pipelines, clinical data, and BD transaction structuring.

• Investor Relations: Outstanding communication and presentation skills in both English and Mandarin, with established relationships with healthcare-focused long-only funds and institutional investors.